XTAI4137
Market cap278mUSD
Dec 24, Last price
110.00TWD
1D
2.33%
1Q
-19.12%
Jan 2017
-26.91%
IPO
-58.00%
Name
Chlitina Holding Ltd
Chart & Performance
Profile
Chlitina Holding Limited, together with its subsidiaries, researches, develops, manufactures, and markets beauty skincare products in China and internationally. It offers makeup removers, facial cleansers, hydrating toners, lotions, moisturizing creams, facial masks, sunscreens, and foundation makeup products; eye care, anti-wrinkle, whitening, and hydrating products; and professional salon botanical extracts, herbal essence products, essential oils, and breast enlargement products under the Chlitina brand name. The company also provides enterprise management consulting services; medical cosmetology services; and cosmetology training services to beauty professionals, as well as operates as a dealer of health food and daily necessities products, skincare and supplementary health care products, and general practice and foods. The company sells its products online. As of December 31, 2019, it operated through a network of 4,809 CHLITINA franchised beauty salons in mainland China, Taiwan, Hong Kong, and South East Asia. Chlitina Holding Limited was founded in 1989 and is headquartered in Grand Cayman, the Cayman Islands.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 4,534,771 11.44% | 4,069,210 -22.80% | 5,271,313 29.96% | |||||||
Cost of revenue | 3,336,882 | 2,889,231 | 3,499,808 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 1,197,889 | 1,179,979 | 1,771,505 | |||||||
NOPBT Margin | 26.42% | 29.00% | 33.61% | |||||||
Operating Taxes | 411,863 | 467,482 | 698,152 | |||||||
Tax Rate | 34.38% | 39.62% | 39.41% | |||||||
NOPAT | 786,026 | 712,497 | 1,073,353 | |||||||
Net income | 1,033,554 49.82% | 689,858 -49.10% | 1,355,257 41.23% | |||||||
Dividends | (556,446) | (953,908) | (675,685) | |||||||
Dividend yield | 3.58% | 6.04% | 3.74% | |||||||
Proceeds from repurchase of equity | 97,176 | (97,176) | ||||||||
BB yield | -0.63% | 0.62% | ||||||||
Debt | ||||||||||
Debt current | 2,104,769 | 582,865 | 1,512,068 | |||||||
Long-term debt | 590,505 | 2,424,853 | 1,998,206 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 2,683 | 2,733 | 3,073 | |||||||
Net debt | (3,707,912) | (3,139,829) | (2,769,960) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,230,096 | 277,546 | 1,797,702 | |||||||
CAPEX | (250,673) | (123,465) | (98,494) | |||||||
Cash from investing activities | (1,369,496) | 962,707 | (578,421) | |||||||
Cash from financing activities | (750,679) | (1,604,041) | (440,232) | |||||||
FCF | 935,985 | 883,028 | 1,214,885 | |||||||
Balance | ||||||||||
Cash | 5,789,769 | 5,644,321 | 7,024,274 | |||||||
Long term investments | 613,417 | 503,226 | (744,040) | |||||||
Excess cash | 6,176,447 | 5,944,086 | 6,016,668 | |||||||
Stockholders' equity | 2,429,558 | 3,450,355 | 3,694,910 | |||||||
Invested Capital | 5,059,787 | 3,707,114 | 4,054,834 | |||||||
ROIC | 17.93% | 18.36% | 28.03% | |||||||
ROCE | 15.81% | 16.45% | 22.62% | |||||||
EV | ||||||||||
Common stock shares outstanding | 79,465 | 79,592 | 79,647 | |||||||
Price | 195.50 -1.51% | 198.50 -12.56% | 227.00 14.65% | |||||||
Market cap | 15,535,408 -1.67% | 15,799,012 -12.62% | 18,079,869 14.87% | |||||||
EV | 11,827,496 | 12,659,183 | 15,309,909 | |||||||
EBITDA | 1,523,257 | 1,523,766 | 2,098,484 | |||||||
EV/EBITDA | 7.76 | 8.31 | 7.30 | |||||||
Interest | 154,890 | 66,906 | 42,265 | |||||||
Interest/NOPBT | 12.93% | 5.67% | 2.39% |